Hirschsprung Disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease.
|
9681515 |
1998 |
Hirschsprung Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
To investigate the contribution of GDNF to the phenotype observed in this kindred, we scanned the coding region of GDNF in the patient with MEN2/HSCR, but no mutation was found.
|
9745455 |
1998 |
Hirschsprung Disease
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
GDNF expression was studied immunohistochemically in surgical specimens from 30 HD cases (27 classic forms and 3 ultralong forms) and from 10 age-matched controls.
|
9473110 |
1998 |
Hirschsprung Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Recent studies have shown that mutations in endothelin-B receptor (EDNRB), endothelin-3, RET, glial cell line-derived neurotrophic factor (GDNF) genes are responsible for the occurrence of congenital aganglionosis.
|
9721987 |
1998 |
Hirschsprung Disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
Moreover, GDNF has been implicated in rare cases of HSCR.
|
9545641 |
1998 |
Hirschsprung Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
GDNF sequence variants including R93W have been suggested previously to represent low penetrance susceptibility mutations for Hirschsprung disease and the R93W was not identified in 376 control alleles studied by others.
|
9215674 |
1997 |
Hirschsprung Disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
As Gdnf and Ret have been linked to the development of Hirschsprung disease (HSCR), it seems likely that Gfra1 could also be a susceptibility gene for HSCR.
|
9465906 |
1997 |
Hirschsprung Disease
|
0.700 |
Biomarker
|
disease |
CTD_human |
Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient.
|
8896568 |
1996 |
Hirschsprung Disease
|
0.700 |
Biomarker
|
disease |
MGD |
Defects in enteric innervation and kidney development in mice lacking GDNF.
|
8657307 |
1996 |
Hirschsprung Disease
|
0.700 |
Biomarker
|
disease |
CTD_human |
De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease.
|
8968758 |
1996 |
Hirschsprung Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease.
|
8896569 |
1996 |
Hirschsprung Disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
No haplotype sharing was evident in any of 36 HSCR kindreds typed for microsatellite markers surrounding GDNF on human chromosome 5p.
|
8896568 |
1996 |
Hirschsprung Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Thus, our data are consistent with a causative role for GDNF mutations in some HSCR cases.
|
8968758 |
1996 |
Hirschsprung Disease
|
0.700 |
Biomarker
|
disease |
HPO |
|
|
|
Pheochromocytoma
|
0.650 |
Biomarker
|
disease |
BEFREE |
RET, a transmembrane receptor tyrosine kinase and a receptor for the glial cell-derived neurotrophic factor family ligands, was one of the first oncogenes to be identified, and has been shown to be an oncogene in thyroid cancer and pheochromocytoma.
|
22751117 |
2013 |
Pheochromocytoma
|
0.650 |
Biomarker
|
disease |
BEFREE |
The RET-activating ligand GDNF was anti-apoptotic for mouse pheochromocytoma but not for PC12 cells.
|
19551609 |
2009 |
Pheochromocytoma
|
0.650 |
Biomarker
|
disease |
BEFREE |
GDNF exerts similar effects on human pheochromocytoma cells in primary cultures.
|
12139916 |
2002 |
Pheochromocytoma
|
0.650 |
Biomarker
|
disease |
BEFREE |
Expression analysis of RET and the GDNF/GFRalpha-1 and NTN/GFRalpha-2 ligand complexes in pheochromocytomas and paragangliomas.
|
10998441 |
2000 |
Pheochromocytoma
|
0.650 |
GeneticVariation
|
disease |
BEFREE |
These findings suggest that although GDNF mutations do not appear to have a major role in the pathogenesis of familial or sporadic phaeochromocytomas, allelic variation at the GDNF locus may modify phaeochromocytoma susceptibility.
|
9215674 |
1997 |
Pheochromocytoma
|
0.650 |
Biomarker
|
disease |
CTD_human |
These findings suggest that although GDNF mutations do not appear to have a major role in the pathogenesis of familial or sporadic phaeochromocytomas, allelic variation at the GDNF locus may modify phaeochromocytoma susceptibility.
|
9215674 |
1997 |
Pheochromocytoma
|
0.650 |
GeneticVariation
|
disease |
UNIPROT |
These findings suggest that although GDNF mutations do not appear to have a major role in the pathogenesis of familial or sporadic phaeochromocytomas, allelic variation at the GDNF locus may modify phaeochromocytoma susceptibility.
|
9215674 |
1997 |
Pheochromocytoma
|
0.650 |
Biomarker
|
disease |
HPO |
|
|
|
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Segregation at three loci explains familial and population risk in Hirschsprung disease.
|
11953745 |
2002 |
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Pathogenesis of Hirschsprung's disease.
|
10917288 |
2000 |
Congenital central hypoventilation
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Mutations of the RET-GDNF signaling pathway in Ondine's curse.
|
9497256 |
1998 |